Christopher J. Rito

(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ

Michael R. Jirousek, James R. Gillig, Cécile Gonzalez et al. · Journal of Medicinal Chemistry · 1996 · 338 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

A Tailored Therapy for the Metabolic Syndrome

Garret J. Etgen, Brian A. Oldham, W. Thomas Johnson et al. · Diabetes · 2002 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Variations in the turn‐forming characteristics of N‐Acyl proline units

Gui‐Bai Liang, Christopher J. Rito, Samuel H. Gellman · Biopolymers · 1992 · 72 citations

Natural Sciences, Biochemistry, Chemistry +12

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids:  A New Class of Dual PPARα/γ Agonists

Dawn A. Brooks, Garret J. Etgen, Christopher J. Rito et al. · Journal of Medicinal Chemistry · 2001 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Thermodynamic analysis of .beta.-turn formation in Pro-Ala, Pro-Gly, and Pro-Val model peptides in methylene chloride

Gui Bai Liang, Christopher J. Rito, Samuel H. Gellman · Journal of the American Chemical Society · 1992 · 60 citations

Life Sciences, Biochemistry, Chemistry +17